Non-smokers can and do develop emphysema. Large population studies consistently find that people who have never touched a cigarette make up a substantial share of emphysema and broader COPD diagnoses. In the international Burden of Obstructive Lung Disease Study, never-smokers accounted for roughly one in five people with moderate-to-severe COPD. The causes range from inherited genetic conditions to workplace dust, secondhand smoke, childhood lung infections, and autoimmune diseases. Because smoking dominates the public conversation around emphysema, non-smokers with the disease often face delayed diagnosis and, paradoxically, stigma borrowed from the very habit they never had.
How Common Is Emphysema in Non-Smokers?
The numbers are larger than most people expect. In the Rotterdam Study, a long-running population-based cohort in the Netherlands, about 6.4 percent of people who had never smoked met the criteria for COPD, compared with roughly 18 percent of those who had ever smoked. Women were disproportionately affected: more than 27 percent of female COPD cases in the study had no smoking history at all, versus about 7 percent of male cases.1PubMed Central. Prevalence and incidence of COPD in smokers and non-smokers: the Rotterdam Study Globally, the Burden of Obstructive Lung Disease Study found that among people with moderate-to-severe airflow obstruction, never-smokers comprised about 23 percent of all cases.2Chest. COPD in Never Smokers: Results From the Population-Based Burden of Obstructive Lung Disease Study
These figures matter because emphysema is just one component of what clinicians group under the COPD umbrella. A person can have emphysema (destruction of the tiny air sacs in the lungs) with or without the chronic bronchitis that often accompanies it. When researchers use CT imaging instead of breathing tests alone, they catch even more non-smokers with emphysema that might otherwise go undetected. The bottom line from the epidemiology is clear: while smoking remains the single biggest risk factor, it is far from the only one.
Genetic Causes
The best-known genetic driver of emphysema in non-smokers is alpha-1 antitrypsin deficiency. Alpha-1 antitrypsin (AAT) is a protein made by the liver that protects the lungs from damage caused by immune cells doing their normal housekeeping. When a mutation in the SERPINA1 gene reduces circulating AAT levels, the lungs gradually lose that shield, and the elastic tissue holding the air sacs open breaks down over time.3PubMed Central. Lung disease in never-smokers with severe α1-antitrypsin deficiency: the EARCO Registry The condition is more common than many clinicians realize, particularly among people of European descent, and it can cause significant emphysema in people who have never smoked a day in their life. If you are diagnosed with emphysema under the age of 50, or if there is a family pattern of early lung disease, testing for AAT deficiency is one of the first steps a pulmonologist should take.
Beyond AAT deficiency, researchers have identified other genetic pathways. Fibrillin-1, a structural protein best known for its role in Marfan syndrome, appears to play a part. A study examining lung tissue found a strong correlation between abnormal fibrillin-1 and the degree of lung destruction, and that correlation held regardless of age or smoking behavior.4PubMed. Aberrant fibrillin-1 expression in early emphysematous human lung: a proposed predisposition for emphysema People with Marfan syndrome, which is caused by fibrillin-1 mutations, sometimes develop emphysema, reinforcing the connection.5PubMed Central. Respiratory manifestations of Marfan syndrome: a narrative review
Elastin mutations form another piece of the puzzle. Elastin is the protein that gives lung tissue its stretch-and-recoil ability, and mutations in the elastin gene have been linked to conditions like autosomal dominant cutis laxa, which can cause emphysema as early as infancy. In severe forms, a recessive mutation in the elastin gene leads to emphysema that appears in newborns.6European Respiratory Review. Mendelian causes of early-onset emphysema: a review of the current literature These rare Mendelian forms of emphysema underscore a broader principle: some people’s lungs are genetically vulnerable to structural breakdown, and smoking simply never enters the picture.
Secondhand Smoke
If you have never lit a cigarette yourself but spent years living or working alongside someone who did, your lungs may still have paid a price. Secondhand smoke is the leading environmental risk factor for COPD in non-smokers. Animal research has shown that chronic secondhand smoke exposure triggers a cascade of inflammatory signals in the lungs, leading to destruction of alveolar walls, loss of blood vessels, and the enlarged airspaces that define emphysema.7PubMed Central. Role of IL-18 in second-hand smoke-induced emphysema
Human data backs this up. A prospective study that followed over 7,000 people for four years found that those exposed to secondhand smoke had about a 50 percent higher risk of developing COPD than those without exposure. Each additional hour of weekly secondhand smoke exposure nudged the risk a little higher, suggesting there is no clearly safe threshold.8Scientific Reports. Secondhand smoke increases the risk of developing chronic obstructive pulmonary disease For non-smokers, this is one of the most actionable risk factors: avoiding indoor environments where people smoke, even briefly, offers measurable protection over years.
Occupational and Indoor Air Exposures
Workplace dust is an underappreciated driver of emphysema. A large Swedish cohort study that included nearly 14,000 never-smokers found that occupational exposure to inorganic dust (the kind produced in mining, construction, and manufacturing) was associated with about a 46 percent increased odds of emphysema among people who had never smoked.9PubMed Central. Workplace Occupational exposures to inorganic dust are associated with emphysema: the SCAPIS cohort A separate European study of construction workers found that non-smokers with airborne dust exposure had roughly double the risk of dying from COPD compared to non-exposed non-smokers.10European Respiratory Journal. Increased mortality in COPD among construction workers exposed to inorganic dust Silica, asbestos, coal dust, and cotton fibers are among the specific culprits, though any prolonged inhalation of fine inorganic particles can damage the lungs over decades.
Indoor cooking and heating with biomass fuels like wood, charcoal, crop residue, and animal dung is another major cause, particularly in low- and middle-income countries. Women in parts of South Asia, Sub-Saharan Africa, and Latin America are especially at risk because they tend to spend more hours near cooking fires in poorly ventilated spaces. Research has highlighted that women face more severe COPD symptoms and higher fatality rates, with biomass fuel exposure identified as a key contributing factor alongside rising smoking rates.11PubMed Central. COPD in females- Seeing through the smoke This helps explain the striking gender gap in the Rotterdam Study data: the high proportion of female COPD cases without any smoking history likely reflects environmental exposures that have nothing to do with cigarettes.
Childhood Lung Development and Early Infections
Emphysema in adulthood sometimes traces back to events that happened before a person was old enough to make any choices about their health at all. The lungs grow rapidly in utero and during the first few years of life, and anything that disrupts that growth can leave someone with a smaller reserve of lung function to draw from for the rest of their life. Research using the Tucson Children’s Respiratory Study cohort tracked children from birth through their early thirties and identified a subset, about 9 percent, who followed a persistently low lung function trajectory. Children who had lower respiratory infections caused by respiratory syncytial virus (RSV) during their first three years were significantly overrepresented in this low trajectory group, with about 41 percent having had an RSV infection compared to 21 percent in the normal group.12PubMed Central. Early life insults as determinants of chronic obstructive pulmonary disease in adult life
The idea is that some people never reach the peak lung function that is normally achieved in early adulthood. If you start lower, even a normal age-related decline can push you past the threshold for a COPD diagnosis decades before it would catch up with someone who reached full lung capacity. Premature birth, low birth weight, maternal smoking during pregnancy, and severe childhood pneumonia are all linked to this reduced starting point. For a non-smoker diagnosed with emphysema in their fifties or sixties, the seeds may have been planted in infancy.
Autoimmune Disease, HIV, and Tuberculosis
Several medical conditions can damage lung tissue in ways that look and behave like smoking-related emphysema. Rheumatoid arthritis stands out. In a study of never-smokers with rheumatoid arthritis-related interstitial lung disease, about 27 percent had emphysema visible on CT scans. The emphysema was associated with worse gas exchange and poorer outcomes, conforming to what pulmonologists call a combined pulmonary fibrosis and emphysema pattern.13PubMed Central. Prevalence and Effects of Emphysema in Never-Smokers with Rheumatoid Arthritis Interstitial Lung Disease The chronic inflammation driven by autoimmune conditions appears to erode lung tissue through mechanisms that overlap with what cigarette smoke does, but the trigger is the immune system itself.
HIV infection is another recognized risk factor. A study comparing never-smoking HIV-positive people to HIV-negative controls found emphysema on CT scans in 18 percent of the HIV group versus just 4 percent of controls. Even after adjusting for age and sex, HIV infection was associated with about four times the odds of having emphysema.14PubMed. Significant chronic airway abnormalities in never-smoking HIV-infected patients The reasons are not fully settled, but chronic immune activation, antiretroviral drug effects, and repeated lung infections all play a role.
Tuberculosis, even after successful treatment, leaves its mark on the lungs. It has been recognized as a significant risk factor for subsequent COPD development, independent of smoking.15PubMed Central. Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPD In parts of the world where TB is common and smoking rates among women are historically low, post-tuberculosis lung disease is a major contributor to the burden of emphysema in non-smokers.
E-Cigarettes and Vaping
One of the newer questions in this space is whether e-cigarettes, often marketed as a safer alternative to traditional cigarettes, can cause emphysema. The human data is still limited because widespread vaping is relatively recent, but animal studies are raising red flags. A long-term mouse study found that chronic exposure to e-cigarette aerosol caused tissue destruction and enlarged airspaces characteristic of emphysema in both male and female mice. Females appeared more susceptible to the e-cigarette aerosol specifically.16PubMed. Long-term e-cigarette aerosol exposure causes pulmonary emphysema in adult female and male mice It will take years of epidemiological follow-up to know whether the same pattern holds in humans, but the animal evidence gives reason for caution. A person who has never smoked traditional cigarettes but vapes regularly should not assume their lungs are unaffected.
What Symptoms Look Like in Non-Smokers
The symptoms of emphysema are the same whether someone smokes or not: progressive shortness of breath that worsens over months to years, a persistent cough, and reduced exercise tolerance. What differs is the context. A published case report described a 55-year-old woman who had never smoked, presenting with worsening shortness of breath and cough. Imaging revealed severe upper-lobe-predominant emphysema, but no identifiable cause could be found, making it a case of so-called idiopathic emphysema.17PubMed Central. Images in COPD: Idiopathic Emphysema in a Never Smoker
That case highlights a common reality: non-smokers with emphysema often go through a longer diagnostic journey. If you have never smoked and your doctor hears “shortness of breath,” the initial workup may focus on asthma, heart problems, or deconditioning before anyone orders the CT scan or pulmonary function tests that would reveal emphysema. The condition tends to be caught later in its course as a result. If you have progressive breathlessness, are winded doing activities that used to be easy, or notice a cough that will not quit, it is worth pushing for a thorough lung evaluation even if smoking has never been part of your life.
When No Cause Can Be Found
Some non-smokers with emphysema go through an extensive workup and come out the other side without a clear explanation. Genetic testing may come back normal. They may have had no significant occupational or environmental exposures, no childhood infections of note, and no autoimmune conditions. The term “idiopathic emphysema” gets applied in these cases, which is essentially a medical way of saying “we don’t know why.” While frustrating for patients, it reflects the reality that our understanding of what causes emphysema is still incomplete. Research into connective tissue proteins like fibrillin-1 and elastin hints that there may be subtler genetic variants, not dramatic enough to cause a named syndrome, that predispose certain people to lung tissue breakdown over time.4PubMed. Aberrant fibrillin-1 expression in early emphysematous human lung: a proposed predisposition for emphysema Future genetic studies using whole-genome approaches will likely reclassify some of today’s idiopathic cases as having a clear molecular explanation.
Combined Pulmonary Fibrosis and Emphysema
A pattern that pulmonologists increasingly recognize is combined pulmonary fibrosis and emphysema (CPFE), where scarring (fibrosis) and tissue destruction (emphysema) coexist in the same patient. This combination is tricky because the two processes can mask each other on breathing tests: fibrosis shrinks the lungs while emphysema over-inflates them, so lung volumes may appear deceptively normal even though gas exchange is severely impaired. CPFE carries a poor prognosis, especially when pulmonary hypertension develops, and there is currently no standard treatment beyond supportive care and managing complications.18World Journal of Advanced Research and Reviews. Diagnosis and treatment of Combined Pulmonary Fibrosis and Emphysema (CPFE) The rheumatoid arthritis data mentioned earlier showed this CPFE pattern appearing in never-smokers, reinforcing that it is not exclusively a smoking-related phenomenon.
The Stigma Problem
Perhaps the most underappreciated challenge facing non-smokers with emphysema is social. COPD is one of the most stigmatized chronic diseases because it is so tightly linked to smoking in the public imagination. Qualitative research has found that people with COPD are acutely aware of blame, both from other people and from themselves, related to the assumption that they brought the disease on themselves through smoking. That blame also comes from healthcare providers.19PubMed Central. The experience of stigma in chronic obstructive pulmonary disease
For someone who never smoked, this stigma can feel particularly unjust. Being asked “how much did you smoke?” by every new doctor, or fielding raised eyebrows from friends when you mention your diagnosis, adds a psychological burden on top of the physical one. Some researchers have argued that COPD-related stigma contributes to underfunding of research relative to the disease’s mortality toll and discourages patients from seeking care or disclosing their diagnosis. If you are a non-smoker dealing with emphysema, know that you are not alone, and that the assumption behind the stigma is factually wrong for a significant share of people living with this disease.
What Non-Smokers Can Do
If you have been diagnosed with emphysema and have never smoked, the first step is making sure a thorough cause investigation has been done. That includes blood testing for AAT deficiency, a detailed occupational and residential history, review of childhood respiratory illness, and screening for autoimmune conditions or past infections like TB. Identifying the cause can sometimes change management. People with AAT deficiency, for instance, may be eligible for augmentation therapy, where the missing protein is given intravenously.
Beyond diagnosis, the management of emphysema in non-smokers overlaps with the general approach: pulmonary rehabilitation (structured exercise and breathing training), bronchodilator inhalers when airflow limitation is present, flu and pneumonia vaccinations to prevent infections that can accelerate decline, and avoiding further environmental exposures. If your workplace involves dust or fumes, respiratory protection matters more for you than for someone whose lungs started at full capacity. The same applies to avoiding secondhand smoke and ensuring good ventilation if biomass fuel is used for cooking or heating.
One practical note on screening: standard spirometry, the breathing test where you blow hard into a tube, can miss early emphysema. CT imaging is more sensitive for detecting the structural destruction of air sacs, especially when the disease is mild. If your symptoms are progressing but your spirometry looks borderline, a chest CT is a reasonable next step to discuss with your doctor.